Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism.
about
Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndromeNeuroimaging in psychiatric pharmacogenetics research: the promise and pitfallsTowards medication-enhancement of cognitive interventions in schizophreniaCOMT val158met moderation of dopaminergic drug effects on cognitive function: a critical reviewModulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibitionOpposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains.Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults.The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males.The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of PennsyInvestigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Inverted-U-shaped dopamine actions on human working memory and cognitive control.COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibitionParadoxical dopaminergic drug effects in extraversion: dose- and time-dependent effects of sulpiride on EEG theta activityThe relationship between dopamine receptor D1 and cognitive performanceCOMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers.Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndromeTolcapone addition improves Parkinson's disease associated nonmotor symptoms.Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease.Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.Safinamide: an add-on treatment for managing Parkinson's disease.
P2860
Q21133920-4E0DD85A-8070-4CA9-9F80-E05A4ED72CBEQ26853551-B24A70A5-1771-4C61-8378-BE1782201A1FQ26860777-BDE4DB0D-2DAD-4E99-8627-C2B96D12C5E1Q28074860-3F7C8B42-E8D4-4ECA-9EE1-1D4F44BF82FDQ28580165-E8EFA3FB-4F3B-4418-A3EF-6457DB70361BQ30439281-8A471C7D-76A8-4508-8181-F47D601F8C85Q30439296-B94E65C9-3277-4A1A-ADC9-D1427CB5D841Q30466238-514C522C-9868-4072-BB95-A361D6AC27AEQ30471555-7794041D-238E-4453-89E9-B7A03187F6F1Q30538175-C2F13E09-EF92-4017-88F2-29660DBDEC27Q34703195-F257B153-0875-49CC-A82B-00F6D754B6EEQ35035569-9539E997-7BC5-49AC-9EE7-D0A92CA5B908Q35859549-2C558A1C-931F-4C53-AB55-C8A3CEA42C9FQ36747324-A3A8A075-CF39-4C80-AF81-02B6D2DA296FQ36848267-E993A8E2-F614-4CF6-972E-B2094BAC78FDQ36909052-09E9A3C7-2AB2-4524-B9D6-58F1F3BEA41BQ37266030-D3F39527-BA27-4909-8796-57014BA5D033Q37599580-B64C0C22-514F-4922-9218-021D153200BBQ38187948-A4170BC8-7615-488E-8AE3-A6BF5E155B6BQ38762256-82FDE891-0F60-45E0-B8CD-46358A73B06FQ38817972-B222AD51-3FAF-4017-8199-9BC4A850F4D7Q39325939-A5B2EC51-EA9D-4260-B3B9-D59FC9EE068DQ50659891-7A89FCDC-2177-4914-8319-747350200C49Q52804779-72599E64-EF41-4907-8A0E-1B067256B3C6
P2860
Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Tolcapone effects on gating, w ...... ferase rs4818c/g polymorphism.
@en
Tolcapone effects on gating, w ...... ferase rs4818c/g polymorphism.
@nl
type
label
Tolcapone effects on gating, w ...... ferase rs4818c/g polymorphism.
@en
Tolcapone effects on gating, w ...... ferase rs4818c/g polymorphism.
@nl
prefLabel
Tolcapone effects on gating, w ...... ferase rs4818c/g polymorphism.
@en
Tolcapone effects on gating, w ...... ferase rs4818c/g polymorphism.
@nl
P1476
Tolcapone effects on gating, w ...... sferase rs4818c/g polymorphism
@en
P2093
Panos Bitsios
Panos Roussos
P304
P356
10.1016/J.BIOPSYCH.2009.07.008
P407
P577
2009-08-22T00:00:00Z